Michael C. Repka

Radiation Oncology

264 Old Country Rd
Mineola, NY 11501

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Sustained Locoregional Control With Deintensified Chemoradiotherapy for HPV Oropharyngeal Carcinoma.

Sustained Locoregional Control With Deintensified Chemoradiotherapy for HPV Oropharyngeal Carcinoma.

Journal: JAMA otolaryngology-- head & neck surgery

Published: April 23, 2026

Toward a Structured Imaging Reporting System for Kidney Masses: The Molecular Imaging Perspective on KI-RADS.

Toward a Structured Imaging Reporting System for Kidney Masses: The Molecular Imaging Perspective on KI-RADS.

Journal: Molecular imaging and biology

Published: March 01, 2026

Navigating Variability in Prostate RT Planning: Real-Time Insights for Human-Centered CDS Design.

Navigating Variability in Prostate RT Planning: Real-Time Insights for Human-Centered CDS Design.

Journal: AMIA ... Annual Symposium proceedings. AMIA Symposium

Published: February 23, 2026

Multi-modality imaging problem-solving for pelvic splenosis on PSMA PET in a patient with recurrent prostate cancer.

Multi-modality imaging problem-solving for pelvic splenosis on PSMA PET in a patient with recurrent prostate cancer.

Journal: BJUI compass

Published: May 30, 2025

Target Delineation in Postoperative Radiation Therapy for Head and Neck Cancer After Flap Reconstruction.

Target Delineation in Postoperative Radiation Therapy for Head and Neck Cancer After Flap Reconstruction.

Journal: Practical radiation oncology

Published: March 26, 2024

Prognostic utility of biopsy-based PTEN and ERG status on biochemical progression and overall survival after SBRT for localized prostate cancer.

Prognostic utility of biopsy-based PTEN and ERG status on biochemical progression and overall survival after SBRT for localized prostate cancer.

Journal: Frontiers in oncology

Published: February 02, 2024

High-risk prostate cancer treated with a stereotactic body radiation therapy boost following pelvic nodal irradiation.

High-risk prostate cancer treated with a stereotactic body radiation therapy boost following pelvic nodal irradiation.

Journal: Frontiers in oncology

Published: October 20, 2023

Corrigendum: Time interval from diagnosis to treatment of brain metastases with stereotactic radiosurgery is not associated with radionecrosis or local failure.

Corrigendum: Time interval from diagnosis to treatment of brain metastases with stereotactic radiosurgery is not associated with radionecrosis or local failure.

Journal: Frontiers in oncology

Published: March 23, 2023

Dosimetric predictors of acute bowel toxicity after Stereotactic Body Radiotherapy (SBRT) in the definitive treatment of localized prostate cancer.

Dosimetric predictors of acute bowel toxicity after Stereotactic Body Radiotherapy (SBRT) in the definitive treatment of localized prostate cancer.

Journal: Acta oncologica (Stockholm, Sweden)

Published: February 24, 2023

Novel VMAT planning technique improves dosimetry for head and neck cancer patients undergoing definitive chemoradiotherapy.

Novel VMAT planning technique improves dosimetry for head and neck cancer patients undergoing definitive chemoradiotherapy.

Journal: Acta oncologica (Stockholm, Sweden)

Published: February 15, 2023

Time interval from diagnosis to treatment of brain metastases with stereotactic radiosurgery is not associated with radionecrosis or local failure.

Time interval from diagnosis to treatment of brain metastases with stereotactic radiosurgery is not associated with radionecrosis or local failure.

Journal: Frontiers in oncology

Published: December 27, 2022

Rationale for Utilization of Hydrogel Rectal Spacers in Dose Escalated SBRT for the Treatment of Unfavorable Risk Prostate Cancer.

Rationale for Utilization of Hydrogel Rectal Spacers in Dose Escalated SBRT for the Treatment of Unfavorable Risk Prostate Cancer.

Journal: Frontiers in oncology

Published: January 23, 2022

Showing 1-12 of 25

Last Updated: 09/26/2026